Detalhe da pesquisa
1.
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Blood
; 141(10): 1159-1168, 2023 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150143
2.
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).
Oncologist
; 29(3): e330-e336, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950903
3.
Association between the Prognostic Nutritional Index and the Occurrence of Immune-Related Adverse Events.
Biol Pharm Bull
; 47(2): 361-365, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311396
4.
Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.
J Infect Dis
; 225(2): 317-326, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844021
5.
[HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide for adult T-cell leukemia].
Rinsho Ketsueki
; 63(5): 333-340, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-35662154
6.
Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience.
Hematol Oncol
; 39(4): 549-557, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117654
7.
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
Jpn J Clin Oncol
; 51(7): 1059-1066, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33959770
8.
Concomitant Nephrotic Syndrome with Diffuse Large B-cell Lymphoma: A Case Report.
Tohoku J Exp Med
; 252(2): 153-157, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028760
9.
HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP.
Retrovirology
; 16(1): 38, 2019 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31842935
10.
Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.
Blood
; 130(1): 39-47, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28515095
11.
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
Hematol Oncol
; 41(3): 590-593, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416678
12.
Erratum to: Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.
J Infect Dis
; 225(2): 359, 2022 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865054
13.
Treatment and survival among 1594 patients with ATL.
Blood
; 126(24): 2570-7, 2015 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26361794
14.
FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
Histopathology
; 68(7): 1099-108, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26426838
15.
A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia/lymphoma.
Cancer Sci
; 106(9): 1219-23, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26179770
16.
A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation.
Ann Hematol
; 99(10): 2449-2451, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32851455
17.
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.
Ann Hematol
; 99(2): 389-390, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848683
18.
Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy.
Support Care Cancer
; 22(7): 1959-64, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24590375
19.
A new era in the management of spinal metastasis.
Front Oncol
; 14: 1374915, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38694784
20.
Current and emerging therapeutic strategies in adult T-cell leukemia-lymphoma.
Int J Hematol
; 117(4): 512-522, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862273